BG62491B1 - Производни на преднизолона - Google Patents
Производни на преднизолона Download PDFInfo
- Publication number
- BG62491B1 BG62491B1 BG100032A BG10003295A BG62491B1 BG 62491 B1 BG62491 B1 BG 62491B1 BG 100032 A BG100032 A BG 100032A BG 10003295 A BG10003295 A BG 10003295A BG 62491 B1 BG62491 B1 BG 62491B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- mmol
- compound
- compounds
- formula
- epimer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH102393 | 1993-04-02 | ||
| PCT/EP1994/001015 WO1994022899A1 (de) | 1993-04-02 | 1994-03-31 | Neue prednisolonderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG100032A BG100032A (bg) | 1996-05-31 |
| BG62491B1 true BG62491B1 (bg) | 1999-12-30 |
Family
ID=4200650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100032A BG62491B1 (bg) | 1993-04-02 | 1995-09-27 | Производни на преднизолона |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5733901A (da) |
| EP (1) | EP0701565B1 (da) |
| JP (1) | JP3333210B2 (da) |
| KR (1) | KR100330941B1 (da) |
| CN (1) | CN1062869C (da) |
| AT (1) | ATE172739T1 (da) |
| AU (1) | AU683463B2 (da) |
| BG (1) | BG62491B1 (da) |
| CZ (1) | CZ287877B6 (da) |
| DE (1) | DE59407183D1 (da) |
| DK (1) | DK0701565T3 (da) |
| ES (1) | ES2124884T3 (da) |
| FI (1) | FI113543B (da) |
| HU (1) | HU220868B1 (da) |
| NO (1) | NO305990B1 (da) |
| NZ (1) | NZ265054A (da) |
| PL (1) | PL179489B1 (da) |
| RU (1) | RU2132854C1 (da) |
| SK (1) | SK281226B6 (da) |
| UA (1) | UA45311C2 (da) |
| WO (1) | WO1994022899A1 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19635498A1 (de) | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Verfahren zur Epimerenanreicherung |
| DE10055820C1 (de) * | 2000-11-10 | 2002-07-25 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung eines Glucocorticoids |
| EA006231B1 (ru) | 2000-11-10 | 2005-10-27 | Алтана Фарма Аг | Способ получения 16,17-[(циклогексилметилен)бис(окси)]-11,21-дигидроксипрегна-1,4-диен-3,20-диона или его 21-изобутирата транскетализацией |
| KR101067795B1 (ko) | 2002-08-30 | 2011-09-27 | 니코메드 게엠베하 | 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도 |
| DK1572217T3 (da) * | 2002-12-12 | 2008-12-15 | Nycomed Gmbh | Kombinationsmedikament af R,R-formoterol og ciclesonid |
| MY143936A (en) * | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
| JP2006527237A (ja) * | 2003-06-13 | 2006-11-30 | アルタナ ファルマ アクチエンゲゼルシャフト | ホルモテロールと及びシクレソニドの組合せ物 |
| WO2005025577A1 (en) * | 2003-09-15 | 2005-03-24 | Altana Pharma Ag | Use of ciclesonide for the treatment of inflammatory bowel diseases |
| US8371292B2 (en) | 2003-09-16 | 2013-02-12 | Nycomed Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
| PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
| US20070134165A1 (en) * | 2004-04-20 | 2007-06-14 | Altana Pharma Ag | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
| JP2008512428A (ja) * | 2004-09-10 | 2008-04-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクレソニドとＳｙｋインヒビターとの組合せ物並びにその使用方法 |
| CN100345864C (zh) * | 2004-10-29 | 2007-10-31 | 天津药业研究院有限公司 | 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体 |
| WO2006138212A1 (en) * | 2005-06-14 | 2006-12-28 | Gilead Sciences, Inc. | SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION |
| WO2007054974A2 (en) * | 2005-09-28 | 2007-05-18 | Arch Pharmalab Limited | A green chemistry process for the preparation of pregnadiene esters |
| WO2008015696A2 (en) * | 2006-05-23 | 2008-02-07 | Cadila Healthcare Limited | Process for preparing ciclesonide |
| JP2010503722A (ja) * | 2006-09-19 | 2010-02-04 | シプラ・リミテッド | シクレソニドとその結晶変異体の調製方法 |
| PT2262823E (pt) * | 2008-03-13 | 2013-03-05 | Farmabios Spa | Processo para a preparação de derivados de pregnano |
| ITMI20080645A1 (it) * | 2008-04-11 | 2009-10-12 | Ind Chimica Srl | Procedimento per la preparazione di budesonide |
| JP5412622B2 (ja) * | 2009-03-09 | 2014-02-12 | 三笠製薬株式会社 | ステロイド化合物 |
| WO2011135585A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Aqueous pharmaceutical solution of ciclesonide |
| US9109005B2 (en) * | 2012-02-23 | 2015-08-18 | Boehringer Ingelheim International Gmbh | Method for manufacturing of ciclesonide |
| CN103421075B (zh) * | 2012-05-16 | 2017-07-28 | 上海特化医药科技有限公司 | 孕烷衍生物16,17‑缩醛(酮)的制备方法 |
| CA3025377A1 (en) | 2016-06-02 | 2017-12-07 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
| PE20201286A1 (es) | 2017-12-01 | 2020-11-24 | Abbvie Inc | Agonista del receptor de glucocorticoides e inmunoconjugados de este |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990401A (en) * | 1958-06-18 | 1961-06-27 | American Cyanamid Co | 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids |
| GB1382614A (en) * | 1972-01-10 | 1975-02-05 | Squibb & Sons Inc | Steroid compositions |
| IT1196142B (it) * | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
-
1994
- 1994-03-31 NZ NZ265054A patent/NZ265054A/xx not_active IP Right Cessation
- 1994-03-31 KR KR1019950704088A patent/KR100330941B1/ko not_active IP Right Cessation
- 1994-03-31 PL PL94311474A patent/PL179489B1/pl unknown
- 1994-03-31 UA UA95094314A patent/UA45311C2/uk unknown
- 1994-03-31 DE DE59407183T patent/DE59407183D1/de not_active Expired - Lifetime
- 1994-03-31 DK DK94913100T patent/DK0701565T3/da not_active Application Discontinuation
- 1994-03-31 AT AT94913100T patent/ATE172739T1/de active
- 1994-03-31 CN CN94191673A patent/CN1062869C/zh not_active Expired - Lifetime
- 1994-03-31 RU RU95119827A patent/RU2132854C1/ru active
- 1994-03-31 ES ES94913100T patent/ES2124884T3/es not_active Expired - Lifetime
- 1994-03-31 CZ CZ19952529A patent/CZ287877B6/cs not_active IP Right Cessation
- 1994-03-31 WO PCT/EP1994/001015 patent/WO1994022899A1/de active IP Right Grant
- 1994-03-31 SK SK1223-95A patent/SK281226B6/sk not_active IP Right Cessation
- 1994-03-31 EP EP94913100A patent/EP0701565B1/de not_active Expired - Lifetime
- 1994-03-31 AU AU65381/94A patent/AU683463B2/en not_active Expired
- 1994-03-31 US US08/530,173 patent/US5733901A/en not_active Expired - Lifetime
- 1994-03-31 JP JP52167794A patent/JP3333210B2/ja not_active Expired - Lifetime
- 1994-03-31 HU HU9502819A patent/HU220868B1/hu unknown
-
1995
- 1995-09-27 FI FI954579A patent/FI113543B/fi not_active IP Right Cessation
- 1995-09-27 BG BG100032A patent/BG62491B1/bg unknown
- 1995-09-29 NO NO19953861A patent/NO305990B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU9502819D0 (en) | 1995-11-28 |
| US5733901A (en) | 1998-03-31 |
| AU683463B2 (en) | 1997-11-13 |
| SK281226B6 (sk) | 2001-01-18 |
| CN1062869C (zh) | 2001-03-07 |
| KR100330941B1 (ko) | 2002-10-12 |
| CN1120339A (zh) | 1996-04-10 |
| NO953861L (no) | 1995-09-29 |
| CZ287877B6 (cs) | 2001-03-14 |
| UA45311C2 (uk) | 2002-04-15 |
| EP0701565B1 (de) | 1998-10-28 |
| ATE172739T1 (de) | 1998-11-15 |
| BG100032A (bg) | 1996-05-31 |
| WO1994022899A1 (de) | 1994-10-13 |
| DE59407183D1 (de) | 1998-12-03 |
| FI954579A0 (fi) | 1995-09-27 |
| AU6538194A (en) | 1994-10-24 |
| FI954579A (fi) | 1995-09-27 |
| JP3333210B2 (ja) | 2002-10-15 |
| NO953861D0 (no) | 1995-09-29 |
| NO305990B1 (no) | 1999-08-30 |
| FI113543B (fi) | 2004-05-14 |
| HU220868B1 (en) | 2002-06-29 |
| NZ265054A (en) | 1997-08-22 |
| DK0701565T3 (da) | 1999-07-12 |
| SK122395A3 (en) | 1996-01-10 |
| HUT72594A (en) | 1996-05-28 |
| JPH08508278A (ja) | 1996-09-03 |
| ES2124884T3 (es) | 1999-02-16 |
| PL311474A1 (en) | 1996-02-19 |
| EP0701565A1 (de) | 1996-03-20 |
| RU2132854C1 (ru) | 1999-07-10 |
| PL179489B1 (pl) | 2000-09-29 |
| CZ252995A3 (en) | 1996-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG62491B1 (bg) | Производни на преднизолона | |
| JP2000501732A (ja) | 抗炎症薬として有用な新規ステロイドナイトライト／ナイトレートエステル誘導体 | |
| CZ292860B6 (cs) | Deriváty androstenu a farmaceutický prostředek obsahující tyto deriváty | |
| DD227966A5 (de) | Verfahren zur herstellung neuer carbonsaeureester | |
| JPS6261599B2 (da) | ||
| FI77668C (fi) | Foerfarande foer framstaellning av nya 16 -metyl-pregnanseriens diklorderivat. | |
| EP0072268B1 (fr) | Stéroides estérifiés en la position 17 et thioestérifiés en la position 21, leur procédé de préparation et leur application comme médicament | |
| US5021408A (en) | Hydrocortisone-17-oxo-21-thioesters, their preparation and their uses as medicaments | |
| US5266566A (en) | Method of treating fungal infections using sterodial ester compounds | |
| JPS6214557B2 (da) | ||
| CA2159627C (en) | Novel prednisolone derivatives | |
| CS231198B2 (en) | Processing method of derivative of 6alpha-methylhydrokortisone | |
| CA1141751A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE HALOGENE DE LA SERIE DU 16.alpha.-METHYL PREGNANE | |
| EP0320253A1 (en) | 21-Alkoxysteroid compounds | |
| NZ200779A (en) | 4-alpha,5-alpha-epoxy-3,20-dioxopregnane-2-alpha | |
| FI63422B (fi) | Analogifoerfarande foer framstaellande av nya 21-salicylsyraestrar och 21-acetylsalicylsyraestrar av steroider ur pregnanserien | |
| CA1250571A (en) | 6 -methylprednisolone derivatives and their manufacture and use | |
| US3763196A (en) | 17-esters of 6alpha-9alpha-difluoro-21-desoxyprednisolone | |
| CS244662B2 (cs) | Způsob výroby nových derivátů 9-chlorprednisolonu | |
| PL112152B1 (en) | Process for preparing novel derivatives of 9-chloroprednisolone | |
| CS244663B2 (cs) | Způsob výroby nových derivátů 9-chlorprednisolonu | |
| CS244147B2 (cs) | Způsob výroby 6<x--methylprednisolonových derivátů | |
| CS248730B2 (cs) | Způsob výroby derivátů Ba-methylkortikoidu |